ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,629.00
0.55%
S&P ASX All Technology
3,016.30
1.48%
Brent Oil
83.385
-0.29%
US Dollar vs AUD
1.50943
-0.82%
Bitcoin
61,711.55
4.38%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. PainReform Ltd (PRFX)

  7. PainReform Ltd (PRFX) News

PRFX PainReform Ltd

0.93
0.01 (1.09%)
Last Updated: 23:43:01
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
PainReform Ltd PRFX NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
0.01 1.09% 0.93 23:43:01
Open Price Low Price High Price Close Price Previous Close
0.93 0.93 0.93 0.92
more quote information »

Recent News

Date Time Source Heading
19/4/202404:19GLOBEPainReform Announces Closing of $4 Million Public Offering
16/4/202422:00GLOBEPainReform Announces Pricing of $4 Million Public Offering
09/4/202423:00GLOBEPainReform’s Non-Opiate Topical Treatment for Post-Surgical..
02/4/202423:30GLOBEPainReform Reaches 50% Enrollment in the Second Part of its..
08/3/202409:25EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
02/3/202408:34EDGAR2Form F-1 - Registration statement for certain foreign..
02/3/202400:09EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
02/3/202400:00GLOBEPainReform Provides Year-End Business Update
01/3/202408:37EDGAR2Form 20-F - Annual and transition report of foreign private..
23/1/202400:30GLOBEPainReform to Present at the Microcap Conference in Atlantic..
22/1/202416:15EDGAR2Form EFFECT - Notice of Effectiveness
20/1/202408:30EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
13/1/202408:15EDGAR2Form F-3 - Registration statement by foreign private issuers
04/1/202400:36EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
04/1/202400:30GLOBEPainReform Reports Successful Head-to-Head Comparison of..
28/12/202308:04EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
28/12/202308:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
27/12/202310:00GLOBEPainReform Announces Exercise of Warrants for Approximately..
16/11/202308:09EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
16/11/202308:05GLOBEPainReform Provides Business Update for the Third Quarter of..
11/9/202322:41EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/9/202322:30GLOBEPainReform Announces Plans to Commence Second Part of Phase..
08/9/202300:00GLOBEPainReform Selected for Poster Presentation at the 13th..
06/9/202306:16EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
05/9/202322:30GLOBEPainReform to Participate in the H.C. Wainwright 25th Annual..
26/8/202306:15EDGAR2Form F-1 - Registration statement for certain foreign..
11/8/202306:18EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/8/202306:05GLOBEPainReform Provides Business Update for the Second Quarter..
19/7/202323:08EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
19/7/202323:00GLOBEPainReform Regains Compliance with Nasdaq Continued Listing..
19/7/202301:59EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
19/7/202301:57EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15/7/202305:45EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15/7/202304:35GLOBEPainReform Announces Pricing of $1.5 Million Concurrent..
15/7/202302:26EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
15/7/202302:17EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/7/202323:23EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/7/202323:05GLOBEPainReform Announces Pricing of $2.7 Million Concurrent..
30/6/202306:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15/6/202322:30GLOBEPainReform to Present at the Maxim Group Virtual Healthcare..
08/6/202306:30GLOBEPainReform Provides Regulatory Update on Second Part of its..
18/5/202323:00GLOBEPainReform Announces Positive Pharmacokinetic (PK) Data in..
16/5/202306:45GLOBEPainReform Provides Business Update for the First Quarter of..

Your Recent History

NASDAQ
PRFX
PainReform
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved